NYC Life Sciences Sector Struggles Amid Investing Dip – Law360 Real Estate Authority

For the second year in a row, New York City’s life sciences industry faced an uphill battle in making gains at the end of 2023 due to the increased federal interest rate, the looming possibility of an economic recession, investments in capital markets “drying up” and declining average asking rents, according to CBRE.